Cervical cancer is a malignant neoplasm arising from cells originating in the cervix uteri. One of the primary types of this cancer is squamous cell carcinoma, which begins in the thin, flat cells lining the outer part of the cervix. Another type is adenocarcinoma, which starts in the glandular cells that line the cervical canal.
This disease is predominantly caused by persistent infection with high-risk types of human papillomavirus (HPV), a common virus transmitted through sexual contact.
HPV is identified as the most significant risk factor for cervical cancer, with types 16 and 18 being the most dangerous. While the virus is common and most sexually active individuals will be infected at some point, not all infections lead to cancer. In many cases, the immune system clears the virus naturally. However, in cases where the virus persists, it can cause changes in the cervical cells, leading to precancerous conditions which, if untreated, may progress to cervical cancer over time.
Routine screening through Pap smears and HPV testing has significantly reduced the incidence and mortality of cervical cancer, especially in developed countries. Pap smears involve collecting cells from the cervix and examining them for abnormalities, while HPV tests detect the presence of the virus itself. Early detection through these screenings allows for the identification and treatment of precancerous lesions before they can develop into invasive cancer.
Symptoms of cervical cancer often do not appear until the disease is in advanced stages, making regular screenings crucial. When symptoms do present, they may include abnormal vaginal bleeding, such as bleeding after intercourse, between periods, or after menopause; unusual vaginal discharge, which may be watery, pink, or foul-smelling; and pelvic pain or pain during intercourse. These symptoms warrant immediate medical attention, as early-stage cervical cancer can often be treated successfully.
Treatment for cervical cancer depends on the stage of the disease, the size of the tumor, and the patient’s overall health and preferences. Early-stage cervical cancer may be treated with surgery, such as a hysterectomy, which involves removing the uterus and cervix, or conization, which involves removing a cone-shaped piece of tissue from the cervix. In some cases, fertility-sparing options are available, such as a trachelectomy, which removes the cervix but leaves the uterus intact.
More advanced stages of cervical cancer may require a combination of surgery, radiation therapy, and chemotherapy. Radiation therapy uses high-energy rays to kill cancer cells, while chemotherapy uses drugs to destroy cancer cells or stop them from growing. For some women, targeted therapy or immunotherapy may be options, particularly in cases where the cancer has spread or recurred. These treatments involve drugs that specifically target cancer cells or help the immune system to recognize and attack cancer cells.
Prevention of cervical cancer largely revolves around reducing the risk of HPV infection. The introduction of HPV vaccines has been a groundbreaking development in this regard. These vaccines are most effective when administered before individuals become sexually active, typically recommended for preteens but can be given up to age 26, and in some cases, up to age 45. The vaccines cover the most common high-risk HPV types that cause cervical cancer, providing a significant reduction in the risk of developing the disease.
In addition to vaccination, regular screening and practicing safe sex, such as using condoms and limiting the number of sexual partners, are critical strategies in preventing HPV infection and consequently, cervical cancer. For women who smoke, quitting smoking is also advised, as smoking has been shown to increase the risk of cervical cancer in HPV-infected women.
Globally, cervical cancer remains a significant public health issue, particularly in low- and middle-income countries where access to screening and vaccination is limited. Efforts to improve access to preventive measures and treatments are crucial in reducing the global burden of cervical cancer. With ongoing research and advancements in medical technology, the hope is to further decrease the incidence and improve the outcomes for those affected by this potentially preventable disease.
